Renal Cancer - Results from #2240

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. January 21, 2021

CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. January 20, 2021

Deep learning based prediction of prognosis in nonmetastatic clear cell renal cell carcinoma. January 20, 2021

Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. January 19, 2021

Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways. January 19, 2021

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC). January 18, 2021

Available active surveillance follow-up protocols for small renal mass: a systematic review. January 18, 2021

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience. January 15, 2021

Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma. January 15, 2021

Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. January 15, 2021

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma. January 14, 2021

Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3. January 14, 2021

Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors (ICIs) in metastatic renal cell carcinoma. January 14, 2021

[Renal cell carcinoma of the kidney transplant: The French guidelines from CTAFU]. January 13, 2021

[Renal cell carcinoma in candidates for renal transplantation and recipients of a kidney transplant: The French guidelines from CTAFU]. January 13, 2021

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival. January 13, 2021

Circ_101341 Deteriorates the Progression of Clear Cell Renal Cell Carcinoma Through the miR- 411/EGLN3 Axis. January 12, 2021

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: a prospective cohort study. January 12, 2021

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports. January 11, 2021

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial. January 11, 2021

Page 113 of 456